An interventional study of Validated quality of life questionnaire (EQ-5D & C-CAP) in Ventricular Tachycardia, ICD and Quality of Life, sponsored by Barts & The London NHS Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-02.
Sponsored by Barts & The London NHS Trust · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 38 studies in Tachycardia, Ventricular with a site in United Kingdom — 12 open to participants now, 14 under way, none of them phase 3. Tachycardia, Ventricular · United Kingdom.
Among the 38 studies in Tachycardia, Ventricular with a site in United Kingdom, this one is the 15th largest by planned enrollment of the 24 interventional ones that give a count, is one of 2 that started in 2024, is one of 23 with no phase, reaches primary completion later than 5 of the 13 other live ones, and was the 21st registered.
452 studies on the registry are indexed under Tachycardia, Ventricular; 121 are open to participants now.
Browse Tachycardia, Ventricular studies →12 of the 38 studies in Tachycardia, Ventricular with a site in United Kingdom are open now. Recruiting first, the newest first:
University of Warwick · Sites in United Kingdom
Ages 18+
Liverpool Heart and Chest Hospital NHS Foundation Trust · Sites in United Kingdom
Ages 18–85
University Hospitals Coventry and Warwickshire NHS Trust · Sites in United Kingdom
Ages 18+
University Hospital, Basel, Switzerland · Sites in United Kingdom, United States, Austria and 13 more countries
Ages 18+
Imperial College London · Sites in United Kingdom
Ages 18+
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 86 Tachycardia, Ventricular studies recruiting now, 67 (78%) set no upper age limit and 1 (1%) stops at 75 or younger; 7 take children under 18; 5 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
38 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 2 started in 2024.
This study's planned enrollment of 70 is close to the median of 70 across 281 interventional studies indexed under Tachycardia, Ventricular.
Median enrollment 94 across the 24 interventional studies, 98 across the 14 observational. Of the 21 that completed or were terminated, 9 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 38 have an industry lead sponsor. The 10 most frequent:
Barts & The London NHS Trust is the lead sponsor of 152 studies on the registry; 22 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Barts & The London NHS Trust has 3 studies filed under Tachycardia, Ventricular — fewer than ten, so there is no comparison to draw.
5 of the studies in Tachycardia, Ventricular with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04520347University of California, Los AngelesIVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry | 2026-12 |
| NCT04499326Barts & The London NHS TrustImproving Patient Reported Outcome Measures in Catheter Ablation | 2026-12-31 |
| NCT03049254Mayo ClinicMayo AVC Registry and Biobank | 2027-03 |
| NCT06384599Adagio MedicalVT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study | 2027-05-01 |
| NCT07759427University of WarwickUsing Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular Tachycardia | 2027-08-31 |
Add all 5 to your calendar (.ics) → With an account.
Among the 38 studies in Tachycardia, Ventricular with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will assess whether more frequent measurement of patient reported outcome measures (PROMs) - specifically health related quality of life (HRQL) - can improve the evaluation of the clinical effectiveness and cost-effectiveness of catheter ablation of ventricular tachycardia (VT) in patients with an Implantable Cardioverter Defibrillator (ICD).
It is designed to have feasibility outcomes which contribute to answering the above.
Patients who have been implanted with an ICD are at risk of suffering from dangerous arrhythmias such as VT.
Patients can experience clinical events including worsening of any underlying heart failure regardless of either VT ablation or medical therapy treatment strategy (anti-arrhythmic drugs (AAD)). VT ablation is a specialist procedure which has been proven in randomised clinical trials (RCTs) to confer symptomatic relief from VT, reduced hospitalisations and reduced shocks from ICDs. However, there is no effect on mortality.
The frequent nature of clinical events in this group of patients may affect their health status quite dramatically and yet based on current trial evidence, only 3 out of 6 randomised trials in VT ablation reported PROMs. This can lead to brittle conclusions about the overall cost-effectiveness profile of a procedure such as VT ablation.
This study will assess for the feasibility of more frequent HRQL monitoring and its impact on whether it is able to better capture the clinical narrative and quality of life changes of patients with severe heart failure and an ICD. And thus the assessment of both clinical effectiveness and cost effectiveness of catheter ablation of VT or continuing anti arrhythmic drug therapy.
METHOD \& SETTING Single centre study at St Bartholomew's Hospital London. Patients will be identified through established local pathways - there are traditional outpatient specialist clinics where Consultant Cardiologists receive referrals of patients for consideration of managing patients with VT, including ablation. In addition, there are joint VT clinics operated by Consultants as well as by cardiac physiologists. In the outpatient VT clinic, 85 patients were seen in a 10-month window - it is assumed that this scale will allow feasible identification of patients to be recruited to the both the groups of this study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Adults (>18 years) With an Implantable Cardioverter Defibrillator (ICD) implanted >3 months from time of recruitment and a previous episode of documented VT requiring therapy from the ICD.
And impaired LV/RV function Willing and able to give written
Exclusion Criteria:
Patients who are planning to move away from study site within 12 months of enrolment who wished to use postal method to complete their HRQL Patients who are unable to give
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients undergoing catheter ablation of VT
Other: Validated quality of life questionnaire (EQ-5D & C-CAP)
Patients undergoing AAD therapy for VT
Other: Validated quality of life questionnaire (EQ-5D & C-CAP)
Patient quality of life to be assessed at baseline, 1, 2, 3, 4, 6, 9 and 12 months
Completion rate of HRQL forms for patients undergoing VT ablation and those starting or continuing AAD therapy
Time frame: 1 year follow up
Recruitment rate of patients who fulfil study criteria
Time frame: 1 year
- Patient preferences for either paper or electronic HQRL (as a percentage of total recruitment)
Time frame: 1 year
Patient reported HRQL of VT ablation and AAD therapy on both EQ-5D and C-CAP
Time frame: 18 months
Impact on the cost-effectiveness calculation of VT ablation (using EQ-5D, and a number of different EQ-5D data points)
Using the Incremental Cost-effectiveness ratio
Time frame: 18 months
Plan to share: Yes — De-identified individual patient data for outcome measures will be made available
Supporting information: Clinical study report
Time frame: In accordance with NHS Research governance framework
Access criteria: Upon reasonable request
No publications or documents are linked to this record.
Started Jun 2024 (actual). Primary completion is estimated for Dec 2026, 30 months after the start.
Of 86 non-industry interventional studies with no phase under Tachycardia, Ventricular, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 25 and three quarters within 70. This study's planned 30 months is below that.
Counting every sponsor, half of 126 studies reached it within 36 months; a quarter within 20 and three quarters within 66.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Barts & The London NHS Trust →